Drupal.behaviors.print = function(context) {window.print();window.close();}>
MDx Firm Prolias Licenses MiRNA IP from Cornell
June 19, 2012
MDx Firm Prolias Licenses MiRNA IP from Cornell
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Empire Genomics Licenses Biomarker from Cornell to Develop Prostate Cancer Dx
May 22, 2013 / GenomeWeb Daily News
Oxford Gene Technology Licenses ICR Prostate Cancer Biomarker Panel
March 13, 2013 / GenomeWeb Daily News
DiaGenic Gets $1.3M Grant for Alzheimer's Dx Project
May 16, 2012 / GenomeWeb Daily News
Asuragen Raises $5M, Targeting $10M in Series C Round
August 12, 2011 / GenomeWeb Daily News
Mira Dx Licenses miRNA Technology for Breast Cancer from Yale
February 24, 2011 / GenomeWeb Daily News